152 related articles for article (PubMed ID: 28947482)
1. Prognosis of Prehypertension Without Progression to Hypertension.
Niiranen TJ; Larson MG; McCabe EL; Xanthakis V; Vasan RS; Cheng S
Circulation; 2017 Sep; 136(13):1262-1264. PubMed ID: 28947482
[No Abstract] [Full Text] [Related]
2. Is it time to target prehypertension.
Whaley-Connell A; Sowers JR
Cardiovasc Ther; 2010 Dec; 28(6):337-8. PubMed ID: 21050419
[No Abstract] [Full Text] [Related]
3. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
Gaddam KK; Ventura H; Lavie CJ
Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
[TBL] [Abstract][Full Text] [Related]
4. Preventing the progression of prehypertension to hypertension: role of antihypertensives.
Fuchs FD; de Mello RB; Fuchs SC
Curr Hypertens Rep; 2015 Jan; 17(1):505. PubMed ID: 25432897
[TBL] [Abstract][Full Text] [Related]
5. Prehypertension is real and can be associated with target organ damage.
Materson BJ; Garcia-Estrada M; Degraff SB; Preston RA
J Am Soc Hypertens; 2017 Nov; 11(11):704-708. PubMed ID: 28965768
[TBL] [Abstract][Full Text] [Related]
6. Prehypertension: the rationale for early drug therapy.
Fuchs FD
Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
[TBL] [Abstract][Full Text] [Related]
7. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012.
Booth JN; Li J; Zhang L; Chen L; Muntner P; Egan B
Hypertension; 2017 Aug; 70(2):275-284. PubMed ID: 28607131
[TBL] [Abstract][Full Text] [Related]
8. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults.
Do HT; Geleijnse JM; Le MB; Kok FJ; Feskens EJ
Am J Hypertens; 2015 Jan; 28(1):89-97. PubMed ID: 24862960
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prehypertension: lifestyle and/or medication.
Collier SR; Landram MJ
Vasc Health Risk Manag; 2012; 8():613-9. PubMed ID: 23172989
[TBL] [Abstract][Full Text] [Related]
10. Exercise capacity and progression from prehypertension to hypertension.
Faselis C; Doumas M; Kokkinos JP; Panagiotakos D; Kheirbek R; Sheriff HM; Hare K; Papademetriou V; Fletcher R; Kokkinos P
Hypertension; 2012 Aug; 60(2):333-8. PubMed ID: 22753224
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Awareness, Treatment, and Control of Hypertension in the Southern Cone of Latin America.
Rubinstein AL; Irazola VE; Calandrelli M; Chen CS; Gutierrez L; Lanas F; Manfredi JA; Mores N; Poggio R; Ponzo J; Seron P; Bazzano LA; He J
Am J Hypertens; 2016 Dec; 29(12):1343-1352. PubMed ID: 27543330
[TBL] [Abstract][Full Text] [Related]
12. Intervention for prehypertension and its cardiovascular risk factors in Inner Mongolia.
Zhao XS; Wang R; Bin LR; Wa SQ
Genet Mol Res; 2014 Jul; 13(3):4867-82. PubMed ID: 25062420
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Prehypertension and Hypertension in Rural India, 2012-2018: A Sex-Stratified Population-Based Prospective Cohort Study.
Rai RK; Kumar C; Singh PK; Singh L; Barik A; Chowdhury A
Am J Hypertens; 2020 May; 33(6):552-562. PubMed ID: 32149333
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population.
Bozorgmanesh M; Ghoreishian H; Mohebi R; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2014 Aug; 21(8):956-63. PubMed ID: 23478742
[TBL] [Abstract][Full Text] [Related]
15. The management of prehypertension in young adults.
Jun M; Xiang Y
Saudi Med J; 2020 Mar; 41(3):223-231. PubMed ID: 32114593
[TBL] [Abstract][Full Text] [Related]
16. Progression from prehypertension to hypertension in a Jamaican cohort: incident hypertension and its predictors.
Ferguson TS; Younger N; Tulloch-Reid MK; Lawrence-Wright MB; Forrester TE; Cooper RS; Van den Broeck J; Wilks RJ
West Indian Med J; 2010 Oct; 59(5):486-93. PubMed ID: 21473394
[TBL] [Abstract][Full Text] [Related]
17. Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population.
Hadaegh F; Hasheminia M; Abdi H; Khalili D; Bozorgmanesh M; Arshi B; Azizi F
PLoS One; 2015; 10(10):e0139412. PubMed ID: 26439847
[TBL] [Abstract][Full Text] [Related]
18. Potential health impact and cost-effectiveness of drug therapy for prehypertension.
Chen T; Yu D; Cornelius V; Qin R; Cai Y; Jiang Z; Zhao Z
Int J Cardiol; 2017 Aug; 240():403-408. PubMed ID: 28501349
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria.
Ononamadu CJ; Ezekwesili CN; Onyeukwu OF; Umeoguaju UF; Ezeigwe OC; Ihegboro GO
Cardiovasc J Afr; 2017 Mar/Apr 23; 28(2):92-99. PubMed ID: 27701484
[TBL] [Abstract][Full Text] [Related]
20. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
